Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Once Daily (QD) Dosing of Lonafarnib (LNF) Co-administered With Ritonavir (RTV) for Treatment of Chronic Hepatitis D Virus Infection

NCT05229991 is registered in ClinicalTrials.gov with Soroka University Medical Center as lead sponsor.

NCT NCT05229991
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05229991 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Once Daily (QD) Dosing of Lonafarnib (LNF) Co-administered With Ritonavir (RTV) for Treatment of Chronic Hepatitis D Virus Infection
Lead sponsor
Soroka University Medical Center
Phase
Phase 3
Overall status
Completed
Start date
May 15, 2021
Completion date
February 5, 2025
Enrollment
10 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis d, chronic